MYC and neoplasm: With respect to targeting of MYC, downregulation of MYC mRNA expression can be achieved by bromodomain and extra-terminal motif (BET) inhibitors in certain tumor types, while targeting the PI3K/mTOR pathway is known to affect both MYC turnover and mRNA translation [46,47,75,259].